Company Filing History:
Years Active: 2023-2024
Title: The Innovations of Jeffrey Mark Dener
Introduction
Jeffrey Mark Dener is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of glucocorticoid receptor modulators. With a total of five patents to his name, Dener's work is characterized by innovative methods and compositions that aim to improve therapeutic outcomes.
Latest Patents
Dener's latest patents include groundbreaking inventions such as "Methods of preparing heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators." This invention provides methods for preparing these modulators while ensuring low impurity levels in the compositions. Another significant patent is for "Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators," which presents crystalline forms of a specific compound and outlines methods for making and using these forms effectively.
Career Highlights
Throughout his career, Jeffrey Mark Dener has been associated with Corcept Therapeutics Incorporated, a company known for its focus on developing innovative treatments for various medical conditions. His work at Corcept has allowed him to contribute to the advancement of therapeutic agents that target glucocorticoid receptors.
Collaborations
Dener has collaborated with several talented individuals in his field, including Hazel Joan Hunt and Lorraine Donaghy. These collaborations have likely enriched his research and contributed to the successful development of his patented inventions.
Conclusion
Jeffrey Mark Dener's contributions to the field of pharmaceutical sciences through his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in medicine.